Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LumiMeds vs TeleHealth Med

LumiMeds
Graded #153

Higher grade

vs+2.3000000000000114
TeleHealth Med
Graded #210

Lower grade

The verdict

LumiMeds takes it — 68.4/100 to 66.1/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +2
76
74
Dose & formulationLumiMeds +1
64
63
Clinical oversightLumiMeds +6
82
76
Labs & monitoringLumiMeds +1
53
52
FulfillmentLumiMeds +2
65
63
Contract termsEven
55
55
LumiMeds · left barTeleHealth Med · right bar

The numbers

MetricLumiMedsTeleHealth Med
WeighScore68.4/10066.1/100
GradeCC
Scorecard rank#153#210
Semaglutide$133/mo (starting dose, compounded)$147/mo (starting dose, compounded)
Tirzepatide$133/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
LumiMeds

Graded #153 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
TeleHealth Med

Graded #210 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard